2023 International Health Cooperation Conference (IHCC) - Special Session of Drum Tower of Nanjing Hospital

• by EVOMT
• 2023-06-21

On the morning of May 29, 2023, the 2023 International Health Cooperation Conference (IHCC) - the academic session of Drum Tower of Nanjing Hospital was successfully held. David C. Reed, Vice Dean of Dana Faber Oncology Hospital affiliated with Harvard Medical School in the United States C. Read) and EVO Medical CEO Ms. Wu Qiuting visited Drum Tower of Nanjing Hospital. Mu Genglin, secretary of the hospital's Party Committee, attended the reception, and relevant personnel from the Party and Government Office and the International Exchange and Cooperation Office attended.

Secretary Mu Genglin warmly welcomed Mr. David C. Reid's visit and introduced the history and development status of Drum Tower of Nanjing Hospital. Drum Tower of Nanjing Hospital currently has more than 6000 employees. It is one of the large comprehensive top three hospitals in China. It has ranked first in the performance appraisal of national three-level public hospitals for four consecutive years, and the latest ranked tenth in the country. It has been incorporated into the pilot hospital for high-quality development of national public hospitals jointly built by selected departments and provinces. It is hoped that through the friendly exchanges between the two sides, Drum Tower of Nanjing Hospital and Dana Farber Cancer Hospital can establish a friendly partnership, especially in the clinical diagnosis and treatment and scientific research in the field of cancer, so as to complement each other's advantages and jointly promote the development of human health.

Mr. David C. Reid introduced Dana Farber Cancer Institute, which is the Harvard Medical School School), which is also a comprehensive cancer treatment center designated by the Federal government of the United States of the United States. It is the leader in cancer treatment in the United States Center) has close cooperation and has obtained 26 certifications from the Food and Drug Administration (FDA). David C. Reid said that he was very happy to visit Drum Tower of Nanjing Hospital on the spot, and expressed his sincere appreciation for the development process of the hospital. He hoped that in the future, the two sides could have in-depth exchanges and achieve multiple cooperation in medical care, education, scientific research and management between hospitals.

Later, Mr. David C. Reid went to the Cancer Medical Center of Drum Tower of Nanjing Hospital for exchange and discussion. He affirmed the work and achievements of the Cancer Medical Center and warmly invited experts in the field of cancer to visit Dana Farber Cancer Research Institute for exchange.

Finally, Drum Tower of Nanjing Hospital would like to thank Mr. Reid for his visit and wonderful sharing. Both sides hope to use the service platform provided by EVO Medical to strengthen academic exchange and cooperation, and jointly promote the development of the medical industry.